SCHEMBL11859518

SCHEMBL11859518

COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)c(O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.59
▸ OPRK1 P41145 1/20 0.58
▸ HSD17B10 Q99714 2/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ THRB P10828 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ TSHR P16473 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ EGFR P00533 1/20 0.52
▸ FYN P06241 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ PTGS1 P23219 1/20 0.52
▸ HTR2A P28223 1/20 0.52
▸ PTGS2 P35354 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ SLC7A5 Q01650 1/20 0.52
▸ HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11850273 1.00 LCK (0.59) LCKOPRK1HSD17B10ALDH1A1THRB
SCHEMBL11849660 0.94 LCK (0.65) LCKOPRK1HSD17B10ALDH1A1THRB
Hydrochloric Acid SCHEMBL11684930 0.93 LCK (0.64) LCKOPRK1HSD17B10ALDH1A1THRB
SCHEMBL11860286 0.91 EGFR (0.55) LCKOPRK1HSD17B10ALDH1A1THRB
SCHEMBL11852840 0.91 EGFR (0.55) LCKOPRK1HSD17B10ALDH1A1THRB
SCHEMBL11861185 0.90 YARS1 (0.53) LCKOPRK1HSD17B10KDM4EUSP2
SCHEMBL11857396 0.90 YARS1 (0.53) LCKOPRK1HSD17B10KDM4EUSP2
SCHEMBL17359622 0.90 LCK (0.58) LCKOPRK1HSD17B10ALDH1A1THRB
SCHEMBL7139809 0.89 OPRK1 (0.69) OPRK1HSD17B10ALDH1A1THRBCYP2C9
SCHEMBL30581396 0.89 OPRK1 (0.69) OPRK1HSD17B10ALDH1A1THRBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3939253-A Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease INTERX RESEARCH CORPORATION (US) 1976-02-17 — — US disclosed
Send feedback